Mabeza, Orlando D.
HRN: 25-63-82 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2024
CEFTRIAXONE 1G (VIAL)
08/10/2024
08/17/2024
IV
2g
Q24
Urosepsis
Waiting Final Action
08/11/2024
CIPROFLOXACIN 500MG (TAB)
08/11/2024
08/17/2024
ORAL
500mg
BID
UTI
Waiting Final Action
08/11/2024
CIPROFLOXACIN 500MG (TAB)
08/11/2024
08/17/2024
ORAL
500mg
BID
UTI
Waiting Final Action
08/14/2024
METRONIDAZOLE 500MG (TAB)
08/14/2024
08/21/2024
PO
500mg
TID
AGE
Waiting Final Action
08/17/2024
CEFTRIAXONE 1G (VIAL)
08/17/2024
08/20/2024
IV
2g
OD
CAP
Waiting Final Action